Viewing Study NCT00049192


Ignite Creation Date: 2025-12-24 @ 3:22 PM
Ignite Modification Date: 2026-02-23 @ 12:23 PM
Study NCT ID: NCT00049192
Status: COMPLETED
Last Update Posted: 2013-06-04
First Post: 2002-11-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module